phenoxybenzamine has been researched along with Dermatitis, Atopic in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VERMA, BS | 1 |
| GULATI, OD | 1 |
| GOKHALE, SD | 1 |
| SHAH, KC | 1 |
| Kramár, J | 1 |
2 other studies available for phenoxybenzamine and Dermatitis, Atopic
| Article | Year |
|---|---|
GUANETHIDINE AND PHENOXYBENZAMINE IN ATOPIC DERMATITIS. A CLINICAL TRIAL.
Topics: Biomedical Research; Dermatitis; Dermatitis, Atopic; Drug Therapy; Eczema; Guanethidine; Humans; Phe | 1964 |
Pharmacodynamic study of the capillaries of normal and allergic (atopic) subjects.
Topics: Adolescent; Adult; Animals; Asthma; Capillary Resistance; Catecholamines; Child; Cyclic AMP; Dermati | 1975 |